Nanya Wang

683 total citations
29 papers, 450 citations indexed

About

Nanya Wang is a scholar working on Oncology, Hepatology and Immunology. According to data from OpenAlex, Nanya Wang has authored 29 papers receiving a total of 450 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 9 papers in Hepatology and 7 papers in Immunology. Recurrent topics in Nanya Wang's work include Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Nanya Wang is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (8 papers), Immune Cell Function and Interaction (5 papers) and Cancer, Lipids, and Metabolism (3 papers). Nanya Wang collaborates with scholars based in China, Russia and United States. Nanya Wang's co-authors include Jiuwei Cui, Wei Li, Chao Niu, Guanjun Wang, Hua He, Hiroshi Terunuma, Haofan Jin, Shuqun Cheng, Yangyang Du and Keke Huang and has published in prestigious journals such as Journal of Clinical Oncology, Clinical Infectious Diseases and Journal of Hepatology.

In The Last Decade

Nanya Wang

27 papers receiving 448 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nanya Wang China	13	150	148	120	86	79	29	450
Haifeng Lin China	8	98 0.7×	108 0.7×	52 0.4×	50 0.6×	55 0.7×	32	303
Wencheng Kong China	11	195 1.3×	90 0.6×	60 0.5×	46 0.5×	110 1.4×	33	435
Shengmian Li China	11	360 2.4×	156 1.1×	100 0.8×	72 0.8×	86 1.1×	34	615
Virginia Belsúe Spain	8	108 0.7×	300 2.0×	278 2.3×	60 0.7×	41 0.5×	16	577
Eufemia Savino Italy	13	164 1.1×	161 1.1×	92 0.8×	25 0.3×	51 0.6×	17	430
Huimin Ma China	11	159 1.1×	79 0.5×	47 0.4×	63 0.7×	61 0.8×	44	389
Tomoaki Iwata Japan	11	113 0.8×	101 0.7×	104 0.9×	157 1.8×	41 0.5×	36	439
P. Langecker United States	11	105 0.7×	152 1.0×	44 0.4×	32 0.4×	59 0.7×	26	489
Weili Sun China	11	138 0.9×	88 0.6×	54 0.5×	28 0.3×	56 0.7×	25	326

Countries citing papers authored by Nanya Wang

Since Specialization

Citations

This map shows the geographic impact of Nanya Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nanya Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nanya Wang more than expected).

Fields of papers citing papers by Nanya Wang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nanya Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nanya Wang. The network helps show where Nanya Wang may publish in the future.

Co-authorship network of co-authors of Nanya Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Nanya Wang. A scholar is included among the top collaborators of Nanya Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nanya Wang. Nanya Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Du, Shunda, Hui‐Chuan Sun, Jinlin Hou, et al.. (2025). LBP-017 SCG101 HBV-specific TCR-T cell therapy demonstrates dual antiviral and antitumor activities, achieving HBV clearance in liver biopsies and functional cure in HBV-related hepatocellular carcinoma patients. Journal of Hepatology. 82. S77–S78. 1 indexed citations

Liu, Yiqian, Liyun Miao, Xiao Chen, et al.. (2024). Maintenance therapy with anlotinib after induction therapy with platinum-based chemotherapy for advanced non-small-cell lung cancer: A pooled analysis of 2 single-arm trials. Medicine. 103(27). e38459–e38459. 1 indexed citations

Liu, Zhanxu, et al.. (2023). Pseudolaric acid B triggers cell apoptosis by activating AMPK/JNK/DRP1/mitochondrial fission pathway in hepatocellular carcinoma. Toxicology. 493. 153556–153556. 12 indexed citations

Ding, Lijuan, et al.. (2023). Midkine inhibition enhances anti-PD-1 immunotherapy in sorafenib-treated hepatocellular carcinoma via preventing immunosuppressive MDSCs infiltration. Cell Death Discovery. 9(1). 92–92. 21 indexed citations

Fan, Zhongqi, Yutao Liu, Chengcheng Li, et al.. (2023). T proliferating cells derived autophagy signature associated with prognosis and immunotherapy resistance in a pan-cancer analysis. iScience. 27(1). 108701–108701. 8 indexed citations

Wang, Nanya, et al.. (2022). Prevalence of SWI/SNF genomic alterations in cancer and association with the response to immune checkpoint inhibitors: A systematic review and meta-analysis. Gene. 834. 146638–146638. 17 indexed citations

Li, Qing, Rui Su, Xin Bao, et al.. (2022). Glycyrrhetinic acid nanoparticles combined with ferrotherapy for improved cancer immunotherapy. Acta Biomaterialia. 144. 109–120. 76 indexed citations

Jia, Lin, Naifei Chen, Xiaohong Chen, et al.. (2022). Sintilimab plus autologous NK cells as second-line treatment for advanced non-small-cell lung cancer previous treated with platinum-containing chemotherapy. Frontiers in Immunology. 13. 1074906–1074906. 14 indexed citations

Wang, Nanya, et al.. (2022). Thrombosis and lymphocyte subsets of COVID-19 omicron BA.2 variant patients with cancer. Frontiers in Oncology. 12. 1048999–1048999.

10.

Li, Hongyan, Menghan Gao, Peng Zhang, et al.. (2022). Association of Nirmatrelvir/Ritonavir Treatment on Upper Respiratory Severe Acute Respiratory Syndrome Coronavirus 2 Reverse Transcription-Polymerase Chain Reaction (SARS-Cov-2 RT-PCR) Negative Conversion Rates Among High-Risk Patients With Coronavirus Disease 2019 (COVID-19). Clinical Infectious Diseases. 76(3). e148–e154. 22 indexed citations

11.

Cui, Jiuwei, Lin Jia, Naifei Chen, et al.. (2022). Sintilimab Plus Autologous NK Cells as Second-Line Treatment for Advanced Non-Small-Cell Lung Cancer Previous Treated with Platinum-Containing Chemotherapy. SSRN Electronic Journal. 1 indexed citations

12.

Sun, Juxian, Chang Liu, Nanya Wang, et al.. (2022). All-Trans-Retinoic Acid Plus Oxaliplatin/Fluorouracil/Leucovorin for Advanced Hepatocellular Carcinoma with Pulmonary Metastasis: A Multicenter Retrospective Study. Cancer Management and Research. Volume 14. 1663–1670. 7 indexed citations

13.

Yin, Liangyu, Chunhua Song, Jiuwei Cui, et al.. (2021). Low fat mass index outperforms handgrip weakness and GLIM-defined malnutrition in predicting cancer survival: Derivation of cutoff values and joint analysis in an observational cohort. Clinical Nutrition. 41(1). 153–164. 20 indexed citations

14.

Ding, Lijuan, Feng Wei, Nanya Wang, et al.. (2021). Tertiary sulphonamide derivatives as dual acting small molecules that inhibit LSD1 and suppress tubulin polymerisation against liver cancer. Journal of Enzyme Inhibition and Medicinal Chemistry. 36(1). 1562–1571. 15 indexed citations

15.

Shi, Jie, Juxian Sun, Chang Liu, et al.. (2019). All-trans-retinoic acid (ATRA) plus oxaliplatin plus 5-fluorouracil/leucovorin (FOLFOX) versus FOLFOX alone as palliative chemotherapy in patients with advanced hepatocellular carcinoma and extrahepatic metastasis: study protocol for a randomized controlled trial. Trials. 20(1). 245–245. 10 indexed citations

16.

Wang, Nanya, et al.. (2018). Factors associated with optimal pain management in advanced cancer patients. Current Problems in Cancer. 43(1). 77–85. 11 indexed citations

17.

Yang, Guang, et al.. (2018). Mangiferin Attenuated Diethynitrosamine-Induced Hepatocellular Carcinoma in Sprague-Dawley Rats via Alteration of Oxidative Stress and Apoptotic Pathway. Journal of Environmental Pathology Toxicology and Oncology. 38(1). 1–12. 13 indexed citations

18.

Qian, Lei, Nanya Wang, Huimin Tian, et al.. (2016). Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients. Journal of Immunology Research. 2016. 1–8. 8 indexed citations

19.

Wang, Nanya, et al.. (2016). Characteristics and prognostic factors for pain management in 152 patients with lung cancer. Patient Preference and Adherence. 10. 571–571. 9 indexed citations

20.

Li, Xia, et al.. (2007). Protective Effect of Velvet Antler Peptides on Acute Hepatic Injury by Carbon Tetrachloride. Zhōnghuá yàoxué zázhì. 1864–1866. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact